LEIDEN, The Netherlands. February 04, 2026 – Leyden Laboratories B.V. (the “Company” or “Leyden Labs”) today announced landmark preclinical and clinical data in Science Translational Medicine supporting the development of their antibody-based nasal sprays to prevent influenza infection by neutralizing virus at…
Levels Dx, a diagnostics company focused on improving early detection of liver cancer, announced the successful close of its latest investment round. The new funding will support a clinical validation study in 300 patients, a critical step in the development…
Researchers from Leiden University Medical Center (LUMC) and the Leiden-based biotech company Ncardia have joined forces to develop a new platform that enables the automated production of 3D cardiac microtissues. Using this platform, large numbers of drugs can be tested…
Dura Vermeer Commercieel Vastgoed and Cellares has signed a long-term lease for a new IDMO Smart Factory in building Nexus (9,741 sqm LFA) at Leiden Bio Science Park. The facility will serve as Cellares’ European headquarters and expand the company’sglobal…
The successful program for stimulating digitization in small and medium-sized businesses in the Leiden and Katwijk region is getting a sequel. Key Region Leiden, in cooperation with the province of South Holland, the participating regional municipalities and the regional entrepreneurs’…
[Amsterdam, 15th December 2025] — Nikon BioImaging Lab Europe (NBIL) is delighted to announce that it has been honoured with the prestigious Deshima Award in the “Newcomer” category. The award recognizes NBIL’s innovative approach, ambitious growth plans, future investments, and…
The publication of the Wennink Report has led to extensive national and regional media coverage on the role of red biotechnology in the future of the Dutch economy and healthcare system. Following its presentation at Nieuwspoort on 12 January, attention…
On December 11th Leiden Bio Science Park participated in the International Talent in South Holland Conference, an inspiring event that marked the launch of a new regional collaboration ‘Work in South Holland’ between the international centers of The Hague, Rotterdam,…
This strategic move allows us to better integrate into this unique community, empowering us to strengthen collaborations with leading researchers and provide exceptional, on-site support to our partners in life science research and pharmaceutical development.
On Tuesday 16 December, Leiden University Medical Center welcomed His Majesty King Willem-Alexander and Minister Jan Anthonie Bruijn of the Ministry of Health, Welfare and Sport for a working visit focused on the future of healthcare. Central themes included the…
Vanmiddag nam minister Jan Anthonie Bruijn van het ministerie van Volksgezondheid, Welzijn en Sport in Leiden, bij het LUMC, het rapport ‘Nederland in de voorhoede: rode biotech als sleutel tot wereldwijde concurrentiekracht; een groeistrategie voor economie, maatschappij en patiënt’ in…
Two Zuid-Holland startups are bringing breakthrough technology into clinical practice. Axite from Leiden and Hologenomix from Delft each receive a €350,000 investment from the proof-of-concept fund UNIIQ to further develop their innovations and bring them to market. Axite: at-home brain monitoring for everyone with a brain condition…